122 related articles for article (PubMed ID: 19733162)
1. A brief review on newborn screening methods for hemoglobinopathies and preliminary results selecting beta thalassemia carriers at birth by quantitative estimation of the HbA fraction.
Mantikou E; Arkesteijn SG; Beckhoven van JM; Kerkhoffs JL; Harteveld CL; Giordano PC
Clin Biochem; 2009 Dec; 42(18):1780-5. PubMed ID: 19733162
[TBL] [Abstract][Full Text] [Related]
2. The significance of the hemoglobin A(2) value in screening for hemoglobinopathies.
Giambona A; Passarello C; Renda D; Maggio A
Clin Biochem; 2009 Dec; 42(18):1786-96. PubMed ID: 19591816
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study.
Balgir RS
J Assoc Physicians India; 2005 Dec; 53():1021-6. PubMed ID: 16572956
[TBL] [Abstract][Full Text] [Related]
4. [Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data].
Fattoum S
Tunis Med; 2006 Nov; 84(11):687-96. PubMed ID: 17294892
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of β-Thalassemia and hemoglobin E in two migrant populations of Manipur, North East India.
Achoubi N; Asghar M; Saraswathy KN; Murry B
Genet Test Mol Biomarkers; 2012 Oct; 16(10):1195-200. PubMed ID: 23057593
[TBL] [Abstract][Full Text] [Related]
6. [Neonatal screening of hemoglobinopathies in a population residing in Portugal].
Peres MJ; Carreiro MH; Machado MC; Seixas T; Picanço I; Batalha L; Lavinha J; Martins MC
Acta Med Port; 1996; 9(4-6):135-9. PubMed ID: 9005686
[TBL] [Abstract][Full Text] [Related]
7. [Advantages in the use of high performance liquid chromatography technique for screening hemoglobinopathies in Venezuela].
Bravo-Urquiola M; Arends A; Montilla S; Velásquez D; Garcìa G; Alvarez M; Guevara J; Castillo O
Invest Clin; 2004 Dec; 45(4):309-15. PubMed ID: 15602897
[TBL] [Abstract][Full Text] [Related]
8. Starting neonatal screening for haemoglobinopathies in The Netherlands.
Giordano PC
J Clin Pathol; 2009 Jan; 62(1):18-21. PubMed ID: 19103852
[TBL] [Abstract][Full Text] [Related]
9. Prospective and retrospective primary prevention of hemoglobinopathies in multiethnic societies.
Giordano PC
Clin Biochem; 2009 Dec; 42(18):1757-66. PubMed ID: 19591814
[TBL] [Abstract][Full Text] [Related]
10. Newborn screening for hemoglobin disorders.
Hoppe CC
Hemoglobin; 2011; 35(5-6):556-64. PubMed ID: 21910601
[TBL] [Abstract][Full Text] [Related]
11. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.
Allaf B; Patin F; Elion J; Couque N
Pediatr Blood Cancer; 2018 Sep; 65(9):e27230. PubMed ID: 29781571
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening for hemoglobinopathies using capillary electrophoresis technology: Testing the Capillarys Neonat Fast Hb device.
Mantikou E; Harteveld CL; Giordano PC
Clin Biochem; 2010 Nov; 43(16-17):1345-50. PubMed ID: 20621075
[TBL] [Abstract][Full Text] [Related]
13. Appropriate thresholds for accurate screening for β-thalassemias in the newborn period: results from a French center for newborn screening.
Allaf B; Pondarre C; Allali S; De Montalembert M; Arnaud C; Barrey C; Benkerrou M; Benhaim P; Bensaid P; Brousse V; Dollfus C; Eyssette-Guerreau S; Galacteros F; Gajdos V; Garrec N; Guillaumat C; Guitton C; Monfort-Gouraud M; Gouraud F; Holvoet L; Ithier G; Kamdem A; Koehl B; Malric A; Missud F; Monier B; Odièvre MH; Joly P; Renoux C; Patin F; Pissard S; Couque N
Clin Chem Lab Med; 2020 Aug; 59(1):209-216. PubMed ID: 32813673
[TBL] [Abstract][Full Text] [Related]
14. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada.
Basran RK; Patterson M; Walker L; Nakamura LM; Eng B; Chui DH; Waye JS
Ann N Y Acad Sci; 2005; 1054():507-10. PubMed ID: 16339708
[TBL] [Abstract][Full Text] [Related]
15. Newborn screening for hemoglobinopathies using capillary electrophoresis.
Giordano PC
Methods Mol Biol; 2013; 919():131-45. PubMed ID: 22976097
[TBL] [Abstract][Full Text] [Related]
16. Thalassemias and other hemoglobinopathies in the Republic of Macedonia.
Efremov GD
Hemoglobin; 2007; 31(1):1-15. PubMed ID: 17365000
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of hemoglobinopathies in newborns in Venezuela hospitals].
Giménez OG; Torrealba MC; Urquiola MB; Ortiz GG; Fonseca SM; Merzón R; de Donato M; Castillo O; Arends de Pérez A
An Pediatr (Barc); 2009 Oct; 71(4):314-8. PubMed ID: 19775947
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
[TBL] [Abstract][Full Text] [Related]
19. Prevention strategies for severe hemoglobinopathies in endemic and nonendemic immigration countries: the Latium example.
Amato A; Grisanti P; Lerone M; Ponzini D; Di Biagio P; Cappabianca MP; Giordano PC
Prenat Diagn; 2009 Dec; 29(12):1171-4. PubMed ID: 19816879
[TBL] [Abstract][Full Text] [Related]
20. Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot study.
Giordano PC; Plancke A; Van Meir CA; Janssen CA; Kok PJ; Van Rooijen-Nijdam IH; Tanis BC; van Huisseling JC; Versteegh FG
Prenat Diagn; 2006 Aug; 26(8):719-24. PubMed ID: 16752436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
